Price
CHART BY
Frequently asked questions
What is Dexcom's market capitalization?
The market capitalization of Dexcom is $31.34B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Dexcom's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Dexcom is 48.10. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Dexcom?
Dexcom's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.668. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Dexcom's stock?
Currently, 26 analysts cover Dexcom's stock, with a consensus target price of $97.19. Analyst ratings provide insights into the stock's expected performance.
What is Dexcom's revenue over the trailing twelve months?
Over the trailing twelve months, Dexcom reported a revenue of $3.95B.
What is the EBITDA for Dexcom?
Dexcom's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $840.40M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Dexcom?
Dexcom has a free cash flow of $535.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Dexcom have, and what sector and industry does it belong to?
Dexcom employs approximately 9,600 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Dexcom's shares?
The free float of Dexcom is 385.65M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $31.34B
- EPS (TTM)
- $1.668
- Free Float
- 385.65M
- P/E ratio (TTM)
- 48.10
- Revenue (TTM)
- $3.95B
- EBITDA (TTM)
- $840.40M
- Free Cashflow (TTM)
- $535.00M
Pricing
- 1D span
- $79.61$80.65
- 52W span
- $62.34$141.99
Analyst Ratings
The price target is $97.19 and the stock is covered by 26 analysts.
Buy
21
Hold
5
Sell
0
Information
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
- Employees
- 9,600
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US2521311074
- Primary Ticker
- DXCM